These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

422 related items for PubMed ID: 9225787

  • 1. In vitro and in vivo detection of functional somatostatin receptors in canine insulinomas.
    Robben JH, Visser-Wisselaar HA, Rutteman GR, van Rijk PP, van Dongen AJ, Voorhout G, van den Ingh TS, Hofland LJ, Lamberts SW.
    J Nucl Med; 1997 Jul; 38(7):1036-42. PubMed ID: 9225787
    [Abstract] [Full Text] [Related]

  • 2. Crucial role for somatostatin receptor subtype 2 in determining the uptake of [111In-DTPA-D-Phe1]octreotide in somatostatin receptor-positive organs.
    Hofland LJ, Lamberts SW, van Hagen PM, Reubi JC, Schaeffer J, Waaijers M, van Koetsveld PM, Srinivasan A, Krenning EP, Breeman WA.
    J Nucl Med; 2003 Aug; 44(8):1315-21. PubMed ID: 12902423
    [Abstract] [Full Text] [Related]

  • 3. 111In-DTPA-D-Phe1-octreotide binding and somatostatin receptor subtypes in thyroid tumors.
    Forssell-Aronsson EB, Nilsson O, Bejegård SA, Kölby L, Bernhardt P, Mölne J, Hashemi SH, Wängberg B, Tisell LE, Ahlman H.
    J Nucl Med; 2000 Apr; 41(4):636-42. PubMed ID: 10768564
    [Abstract] [Full Text] [Related]

  • 4. Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy.
    Lamberts SW, Hofland LJ, van Koetsveld PM, Reubi JC, Bruining HA, Bakker WH, Krenning EP.
    J Clin Endocrinol Metab; 1990 Sep; 71(3):566-74. PubMed ID: 2168430
    [Abstract] [Full Text] [Related]

  • 5. Iodination of [Tyr11]somatostatin yields a super high affinity ligand for somatostatin receptors in GH4C1 pituitary cells.
    Presky DH, Schonbrunn A.
    Mol Pharmacol; 1988 Nov; 34(5):651-8. PubMed ID: 2904115
    [Abstract] [Full Text] [Related]

  • 6. Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide.
    Barone R, Walrand S, Konijnenberg M, Valkema R, Kvols LK, Krenning EP, Pauwels S, Jamar F.
    Nucl Med Commun; 2008 Mar; 29(3):283-90. PubMed ID: 18349800
    [Abstract] [Full Text] [Related]

  • 7. Hepatobiliary handling of iodine-125-Tyr3-octreotide and indium-111-DTPA-D-Phe1-octreotide by isolated perfused rat liver.
    de Jong M, Bakker WH, Breeman WA, van der Pluijm ME, Kooij PP, Visser TJ, Docter R, Krenning EP.
    J Nucl Med; 1993 Nov; 34(11):2025-30. PubMed ID: 8229254
    [Abstract] [Full Text] [Related]

  • 8. Fish somatostatin sst3 receptor: comparison of radioligand and GTPgammaS binding, adenylate cyclase and phospholipase C activities reveals different agonist-dependent pharmacological signatures.
    Siehler S, Nunn C, Zupanc GK, Hoyer D.
    Auton Autacoid Pharmacol; 2005 Jan; 25(1):1-16. PubMed ID: 15659149
    [Abstract] [Full Text] [Related]

  • 9. Somatostatin receptor subtypes in human thymoma and inhibition of cell proliferation by octreotide in vitro.
    Ferone D, van Hagen MP, Kwekkeboom DJ, van Koetsveld PM, Mooy DM, Lichtenauer-Kaligis E, Schönbrunn A, Colao A, Lamberts SW, Hofland LJ.
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1719-26. PubMed ID: 10770220
    [Abstract] [Full Text] [Related]

  • 10. Tissue distribution and metabolism of radioiodinated DTPA0, D-Tyr1 and Tyr3 derivatives of octreotide in rats.
    Breeman WA, de Jong M, Bernard B, Hofland LJ, Srinivasan A, van der Pluijm M, Bakker WH, Visser TJ, Krenning EP.
    Anticancer Res; 1998 Apr; 18(1A):83-9. PubMed ID: 9568060
    [Abstract] [Full Text] [Related]

  • 11. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study.
    Bertherat J, Tenenbaum F, Perlemoine K, Videau C, Alberini JL, Richard B, Dousset B, Bertagna X, Epelbaum J.
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773
    [Abstract] [Full Text] [Related]

  • 12. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas.
    Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, Reading CC, Moertel C.
    Cancer Res; 1990 Sep 15; 50(18):5969-77. PubMed ID: 2168286
    [Abstract] [Full Text] [Related]

  • 13. Identification and pharmacological characterization of somatostatin receptors in rat lung.
    Schloos J, Raulf F, Hoyer D, Bruns C.
    Br J Pharmacol; 1997 Jul 15; 121(5):963-71. PubMed ID: 9222554
    [Abstract] [Full Text] [Related]

  • 14. Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
    Virgolini I, Traub T, Novotny C, Leimer M, Füger B, Li SR, Patri P, Pangerl T, Angelberger P, Raderer M, Burggasser G, Andreae F, Kurtaran A, Dudczak R.
    Curr Pharm Des; 2002 Jul 15; 8(20):1781-807. PubMed ID: 12171531
    [Abstract] [Full Text] [Related]

  • 15. Localization of neuroendocrine tumours and insulinomas using radiolabelled somatostatin analogues, 123I-Tyr3-octreotide and 111In-pentatreotide.
    Ur E, Bomanji J, Mather SJ, Britton KE, Wass JA, Grossman AB, Besser GM.
    Clin Endocrinol (Oxf); 1993 May 15; 38(5):501-6. PubMed ID: 8101146
    [Abstract] [Full Text] [Related]

  • 16. Somatostatin receptor scintigraphy using [111In-DTPA0]RC-160 in humans: a comparison with [111In-DTPA0]octreotide.
    Breeman WA, van Hagen PM, Kwekkeboom DJ, Visser TJ, Krenning EP.
    Eur J Nucl Med; 1998 Feb 15; 25(2):182-6. PubMed ID: 9473268
    [Abstract] [Full Text] [Related]

  • 17. Therapy of neuroendocrine tumors with radiolabeled somatostatin-analogues.
    De Jong M, Breeman WA, Bernard HF, Kooij PP, Slooter GD, Van Eijck CH, Kwekkeboom DJ, Valkema R, Mäcke HR, Krenning EP.
    Q J Nucl Med; 1999 Dec 15; 43(4):356-66. PubMed ID: 10731786
    [Abstract] [Full Text] [Related]

  • 18. Indirect antiproliferative effect of the somatostatin analog octreotide on MIA PaCa-2 human pancreatic carcinoma in nude mice.
    Weckbecker G, Raulf F, Bodmer D, Bruns C.
    Yale J Biol Med; 1997 Dec 15; 70(5-6):549-54. PubMed ID: 9825482
    [Abstract] [Full Text] [Related]

  • 19. Internalization of [DOTA degrees,125I-Tyr3]Octreotide by somatostatin receptor-positive cells in vitro and in vivo: implications for somatostatin receptor-targeted radio-guided surgery.
    Hofland LJ, Breeman WA, Krenning EP, de Jong M, Waaijers M, van Koetsveld PM, Mäcke HR, Lamberts SW.
    Proc Assoc Am Physicians; 1999 Dec 15; 111(1):63-9. PubMed ID: 9893158
    [Abstract] [Full Text] [Related]

  • 20. [125I][Tyr3]octreotide labels human somatostatin sst2 and sst5 receptors.
    Siehler S, Seuwen K, Hoyer D.
    Eur J Pharmacol; 1998 May 08; 348(2-3):311-20. PubMed ID: 9652348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.